Cargando…

Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma

Background: Recent studies have identified several molecular subgroups of medulloblastoma associated with distinct clinical outcomes; however, no robust gene signature has been established for prognosis prediction. Our objective was to construct a robust gene signature-based model to predict the pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chang, Zou, Han, Xiong, Zujian, Xiong, Yi, Miyagishima, Danielle F., Wanggou, Siyi, Li, Xuejun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249855/ https://www.ncbi.nlm.nih.gov/pubmed/32508873 http://dx.doi.org/10.3389/fgene.2020.00429

Ejemplares similares

Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
por: Xiong, Yi, et al.
Publicado: (2020)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Clinical characteristics, surgical management, and prognostic factors for supratentorial hemangioblastoma: A retrospective study
por: Chen, Long, et al.
Publicado: (2023)

Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer
por: Wang, Dengchuan, et al.
Publicado: (2023)

Identification of purity and prognosis‐related gene signature by network analysis and survival analysis in brain lower grade glioma
por: Xiong, Zujian, et al.
Publicado: (2020)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q
por: Zou, Han, et al.
Publicado: (2020)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
por: Ding, Jianfeng, et al.
Publicado: (2022)

Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients
por: Zhang, Wenqi, et al.
Publicado: (2021)

Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer
por: Hu, Xiao-Qian, et al.
Publicado: (2022)

Construction and Validation of a 6-Ferroptosis Related Gene Signature for Prognosis and Immune Landscape Prediction in Melanoma
por: Yue, Zhanghui, et al.
Publicado: (2022)

Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients
por: Ye, Ningrong, et al.
Publicado: (2019)

Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021)

Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer
por: Li, Xianzhe, et al.
Publicado: (2021)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022)

Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer
por: Li, Jianxin, et al.
Publicado: (2022)

Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation
por: Liu, Zijian, et al.
Publicado: (2022)

Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer
por: Yu, Jing, et al.
Publicado: (2021)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
por: Tan, Jun, et al.
Publicado: (2021)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
por: Han, Songling, et al.
Publicado: (2021)

Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer
por: Wang, Bofang, et al.
Publicado: (2022)

Construction and Validation of a Novel Glycometabolism-Related Gene Signature Predicting Survival in Patients With Ovarian Cancer
por: Liu, Lixiao, et al.
Publicado: (2020)

Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
por: Meng, Tongyu, et al.
Publicado: (2022)

Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
por: Wu, Ming, et al.
Publicado: (2017)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

Development and Validation of a Ferroptosis-Related Gene Signature and Nomogram for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma
por: Ye, Jiecheng, et al.
Publicado: (2021)

Construction of a fatty acid metabolism-related gene signature for predicting prognosis and immune response in breast cancer
por: Qian, Li, et al.
Publicado: (2023)

Construction and validation of a novel and superior protein risk model for prognosis prediction in esophageal cancer
por: Liu, Yang, et al.
Publicado: (2022)

Constructing a signature based on the SIRT family to help the prognosis and treatment sensitivity in glioma patients
por: Xuan, Feiyue, et al.
Publicado: (2022)

Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma
por: Zhu, Sihan, et al.
Publicado: (2020)

Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer
por: Liu, Li, et al.
Publicado: (2023)

Construction and validation of a novel cuproptosis-related long noncoding RNA signature for predicting the outcome of prostate cancer
por: Jiang, Shaoqin, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma
por: Hu, Tianhao, et al.
Publicado: (2022)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2021)

Systematic Analysis of 4-gene Prognostic Signature in Patients with Diffuse Gliomas Based on Gene Expression Profiles
por: Huang, Chunhai, et al.
Publicado: (2021)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_811fvl00ajmhjqflmh96tfmgiu